Lazard Asset Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-42,173
Closed -$705K 2481
2024
Q3
$705K Buy
+42,173
New +$907K ﹤0.01% 1243
2024
Q1
Sell
-4,256
Closed -$154K 2309
2023
Q4
$154K Buy
+4,256
New +$164K ﹤0.01% 1486
2023
Q2
Sell
-1,228
Closed -$59K 2490
2023
Q1
$59K Buy
+1,228
New +$64.9K ﹤0.01% 1742
2022
Q4
Sell
-1,733
Closed -$105K 2529
2022
Q3
$105K Hold
1,733
﹤0.01% 1454
2022
Q2
$47K Hold
1,733
﹤0.01% 1848
2022
Q1
$63K Buy
1,733
+657
+61% +$23.7K ﹤0.01% 1626
2021
Q4
$53K Buy
1,076
+158
+17% +$8.76K ﹤0.01% 1715
2021
Q3
$65K Buy
+918
New +$57K ﹤0.01% 1566

Other funds holding PRTA

Lazard Asset Management's PRTA Position: Q4 2024 in Review

Lazard Asset Management sold out of Prothena Corp (PRTA) in Q4 2024, closing a stake of 42,173 shares — an estimated $705K sold.

Lazard Asset Management first reported a position in PRTA in Q3 2021 and held it in 8 quarters. The position peaked at $705K in Q3 2024. 170 funds tracked by Wall St. Rank hold PRTA as of Q4 2024.

  • Lazard Asset Management reported no remaining Prothena Corp position as of Q4 2024 after selling out during the quarter.
  • Lazard Asset Management sold 42,173 Prothena Corp shares in Q4 2024, an estimated $705K.
  • Lazard Asset Management first reported a position in Prothena Corp in Q3 2021 and held it in 8 quarters.
  • Lazard Asset Management's Prothena Corp position peaked at $705K in Q3 2024.
  • 170 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2024.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.